MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

Handheld Echocardiography in Clinical Practice

Completed

Conditions: Cardiovascular Disease

First Posted Date: 2012-03-20

Last Posted Date: 2013-07-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 200

Registration Number: NCT01558518

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Lp-PLA2 and Coronary Atherosclerosis in Humans

Not Applicable

Completed

Conditions: Coronary Atherosclerosis
Endothelial Dysfunction

First Posted Date: 2012-03-19

Last Posted Date: 2015-09-23

Lead Sponsor: Mayo Clinic

Target Recruit Count: 166

Registration Number: NCT01557088

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

Phase 4

Terminated

Conditions: Thrombophilia Due to Acquired Antithrombin III Deficiency

Interventions: Drug: Recombinant antithrombin (rhAT)

First Posted Date: 2012-03-08

Last Posted Date: 2015-07-15

Lead Sponsor: Mayo Clinic

Target Recruit Count: 42

Registration Number: NCT01547728

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure

Phase 1

Completed

Conditions: Congestive Heart Failure

Interventions: Drug: Nesiritide
Drug: Tadalafil
Drug: Placebo
Drug: Saline load

First Posted Date: 2012-03-06

Last Posted Date: 2018-03-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 43

Registration Number: NCT01544998

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Does Class of Dietary Fat Affect Insulin Resistance?

Not Applicable

Completed

Conditions: Insulin Resistance

Interventions: Other: Dietary fat

First Posted Date: 2012-03-01

Last Posted Date: 2014-11-26

Lead Sponsor: Mayo Clinic

Target Recruit Count: 24

Registration Number: NCT01541592

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery

Phase 1

Completed

Conditions: Acinar Cell Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage IV Pancreatic Cancer
Duct Cell Adenocarcinoma of the Pancreas
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: vismodegib
Drug: sirolimus
Procedure: positron emission tomography
Procedure: computed tomography
Other: pharmacological study
Other: laboratory biomarker analysis
Radiation: fludeoxyglucose F 18

First Posted Date: 2012-02-23

Last Posted Date: 2019-04-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 31

Registration Number: NCT01537107

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Mayo Clinic Campus in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic Campus in Arizona, Scottsdale, Arizona, United States

Sensitivity to Change of the Lower Extremity Functional Scale in Patients With Stroke

Completed

Conditions: Lower Extremity Dysfunction
Stroke

First Posted Date: 2012-02-22

Last Posted Date: 2023-08-31

Lead Sponsor: Mayo Clinic

Target Recruit Count: 39

Registration Number: NCT01536990

Locations: 🇺🇸
Mayo Clinic, Scottsdale, Arizona, United States

Stiripentol in Dravet Syndrome

Conditions: Dravet Syndrome

First Posted Date: 2012-02-15

Last Posted Date: 2013-02-28

Lead Sponsor: Mayo Clinic

Registration Number: NCT01533506

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography

Completed

Conditions: Cardiac Allograft Vasculopathy

First Posted Date: 2012-02-07

Last Posted Date: 2014-05-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 82

Registration Number: NCT01527344

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging

Phase 1

Terminated

Conditions: Congestive Heart Failure

Interventions: Drug: 123 iodine metaiodobenzylguanidine

First Posted Date: 2012-01-31

Last Posted Date: 2017-04-26

Lead Sponsor: Mayo Clinic

Target Recruit Count: 14

Registration Number: NCT01522378

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy